Synovial lymphoid neogenetic factors in Behçet's synovitis: Do they play a role in self-limiting and subacute course of arthritis?

Clinical and Experimental Rheumatology

Volumn 25, Issue 4 SUPPL. 45, 2007, Pages

  Pay, Salih ^a   Musabak, Ugur ^a   Simsek, Ismail ^a   Erdem, Hakan ^a   Pekel, Aysel ^a   Sengul, Ali ^a   Dinc, Ayhan ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Arthritis; Beh et's disease; Chemokines; Lymphoid neogenesis; Pathogenesis

Indexed keywords

BETA INTERFERON; CHEMOKINE; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CXCL13 CHEMOKINE; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; LYMPHOCYTE RECEPTOR;

ADULT; APOPTOSIS; ARTHRITIS; ARTICLE; BEHCET DISEASE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; LYMPHANGIOGENESIS; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; SYNOVITIS; T LYMPHOCYTE; KNEE ARTHRITIS; MAJOR CLINICAL STUDY;

ADULT; ARTHRITIS, RHEUMATOID; BEHCET SYNDROME; CASE-CONTROL STUDIES; CHEMOKINE CCL21; CHEMOKINE CXCL12; CHEMOKINE CXCL13; FEMALE; HUMANS; INTERFERON-BETA; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; RECEPTORS, CHEMOKINE; SYNOVIAL FLUID; SYNOVITIS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 35448981937     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. MANZO A, CAPORALI R, MONTECUCCO C, PITZALIS C: Role of chemokines and chemokine receptors in regulating specific leukocyte trafficking in immune/inflammatory response. Clin Exp Rheumatol 2003; 21: 501-8.
2. VERGUNTT CE, TAK PP: Chemokines: their role in rheumatoid arhritis. Curr Rheumatol Rep 2005; 7: 382-8.
3. STRIETER RM, BURDICK MD, GOMPERTS BN, BELPERIO JA, KEANE MP: CXC Chemokines in angiogenesis. Cytokine Growth Fac Rew 2005; 16: 593-609.
4. MOSER B, LOETSCHER P: Lymphocyte traffic control by chemokines. Nature Immunology 2001; 2: 1-7.
5. ESCHE C, STELLATO C, BECK LA: Chemokines: Key players in innate and adaptive immunity. J Invest Dermatol 2005; 125: 615-28.
6. WENINGER W, VON ANDRIAN UH: Chemokine regulation naive T cell traffic in health and disease. Semin Immunol 2003; 15: 257-70.
7. HJELMSTORM P: LDmphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation of homing chemokines. J Leukoc 2001; 69: 331-9.
8. BUCKLEY CD: Why do leucocytes accumulate within chronically inflamed joints? Rheumatology 2003; 42: 1433-44.
9. CARLSEN HS, BAEKKEVOLD ES, MORTON HC, HARELDSEN G, BRANDTZAEG P: Monocyte-like and mature macrophages produce CXCL13 in inflammatory lesions with lymphoid neogenesis. Blood 2004; 104: 3021-7.
10. HJELMSTORM P, FJELL J, NAKAGAWA T, SACCA R, CUFF CA, RUDDLE NH: Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am J Pathol 2000; 156: 1133-8.
11. TAKEMURA S, BRAUN A, CROWSON C et al.: Lymphoid neogenesis in rheumatoid arthritis. J Immunol 2001; 167: 1072-80.
12. SOLOMONSSON S, LARSSON P, TENGNER P, MELLQUIST E, HIELMSTORM P, WAHRENHERLENIUS M: Expression of the B cell-attrcting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren syndrome. Scand J Immunol 2002; 55: 336-42.
13. WENINGER W, CARLSEN H, GOODARZI M et al.: Naive T cell recruitment to nonlymphoid tissues: A role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis. J Immunol 2003; 170: 4638-48.
14. SOLOMONSSON S, JOHNSSON MV, SKARSTEIN K et al.: Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren syndrome. Arthritis Rheum 2003; 48: 3187-201.
15. MANZO A, PAOLETTI S, CARULLI M et al.: Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur J Immunol 2005; 35: 1347-59.
16. SCHMUTZ C, HULME A, BURMAN A et al.: Chemokine receptors in the rheumatoid synovium: Upregulation of CXCR5. Arthritis Res Ther 2004; 7: R217-R229.
17. BUCKLEY CD, AMFF N, BRADFIELD PF et al.: Persistent induction of the chemokine receptor CXCR4 by TGF-β1 on synovial T cells contributes to their accumulation with rheumatoid synovium. J Immunol 2000; 165: 3423-9.
18. MATTHYS P, HATSE S, VERMEIRE K et al.: AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-γ receptor deficient mice. J Immunol 2001; 167: 4686-92.
19. SALMON M, SCHEEL-TOELNER D, HUISSON A et al.: Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest 1997; 99: 439-46.
20. PILLING D, AKBAR AN, GIRDLESTONE J et al.: Interferon-β mediates stromal cell resscue of T cells from apoptosis. Eur J Immunol 1999; 29: 1041-50.
21. PAY S, ERDEM H, SERDAR M, DINÇ A, ŞIMŞEK I, TURAN M: Comparison of Synovial MMP-1 and TIMP-1 Levels in Patients with Various Inflammatory Arthritides: Is There Any Difference Between Rheumatoid Arthritis, Behçet's Disease and Familial Mediterranean Fever? Clinical Rheumatology 2002; 21: 511-5.
22. PAY S, ERDEM H, PEKEL A, ŞIMŞEK I, MUŞABAK U, ŞENGÜL A, DINÇ A: Synovial Proinflammatory Cytokines and Their Correlation with Matrix Metalloproteinase-3 Expression in Behçet's Disease. Does Interleukin-1β Play a Major Role in Behçet's Synovitis? Rheumatol Int 2005 (online).
23. ERDEM H, PAY S, SERDAR M et al.: Different ELR(+) angiogenic CXC chemokine profiles in synovial fluid of patients with Behçet's disease, familial Mediterranean fever, rheumatoid arthritis, and osteoarthritis. Rheumatol Int 2004 (online).
24. PAY S, MUŞABAK U, ŞIMŞEK I et al.: Expression of CXCR-1 and CXCR-2 chemokine receptors on synovial neutrophils in inflammatory arthritides: Does persistent or increasing expression of CXCR2 contribute to the chronic inflammation or erosive changes? ANNUAL EUROPEAN CONGRESS ON RHEUMATOLOGY-EULAR 2005, 7-11 June 2005.
25. INTERNATIONAL STUDY GROUP FOR BEHÇET'S DISEASE: Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
26. CALABRESE LH, MICHEL BA, BLOCH DA: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1990; 33: 1108-3.
27. ALTMAN RD: Criteria for classification of clinical osteoarthritis. J Rheumatol 1991; 18: 10-12.
28. BUCKLEY CD: Why does chronic inflammatory joint disease persist? Clin Med 2003; 3: 361-6.
29. LUTHER SA, LOPEZ T, BAI W, HANAHAN D, CYSTER JG: BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 2000; 12: 471-81.
30. + cell migration within synovial tissue. Arthritis Rheum 2003; 48: 2472-82.
31. LETTERIO JJ, ROBERTS AB: Regulation of immune responses by TGF-β. Annu Rev Immunol 1998; 137-61.
32. VAN DEN BERG WB: Joint inflammation and cartilage destruction may occur uncoupled. Semin Immunopathol 1998; 20: 149-64.